Cervical cancer screening and adherence to follow-up among Hispanic women study protocol: a randomized controlled trial to increase the uptake of cervical cancer screening in Hispanic women

BMC Cancer

Catherine Duggan⁴  Gloria Coronado¹  Javiera Martinez³  Theresa L Byrd⁶  Elizabeth Carosso⁴  Cathy Lopez²  Maria Benavides⁵  Beti Thompson⁴ 

[1] Kaiser Permanente Center for Health Research, Portland, OR, USA

[2] Breast, Cervical and Colon Health Program of Yakima Valley, Yakima, WA, USA

[3] Department of Family Medicine Pontificia, Universidad Catolica de Chile, Santiago, Chile

[4] Public Health Sciences, Fred Hutchinson Cancer Research Centre, Seattle, WA, 98109, USA

[5] Yakima Valley Farmworkers Clinic, Yakima, WA, USA

[6] Texas Tech Paul L Foster School of Medicine, El Paso, TX, USA

关键词: Cancer disparities;    Cervical cancer screening;    Pap test;    Hispanic women;   

Others  :  1080437
DOI  :  10.1186/1471-2407-12-170

 received in 2012-03-12, accepted in 2012-05-06,  发布年份 2012

【 摘 要 】

Background

In the US, Hispanic women have a higher incidence of, and mortality from, cervical cancer than non-Hispanic white women. The reason for this disparity may be attributable to both low rates of screening and poor adherence to recommended diagnostic follow-up after an abnormal Pap test. The 'Cervical Cancer Screening and Adherence to Follow-up Among Hispanic Women' study is a collaboration between a research institution and community partners made up of members from community based organizations, the Yakima Valley Farm Workers Clinic and the Breast, Cervical, and Colon Health Program of the Yakima District . The study will assess the efficacy of two culturally-appropriate, tailored educational programs designed to increase cervical cancer screening among Hispanic women, based in the Yakima Valley, Washington, US.

Methods/design

A parallel randomized-controlled trial of 600 Hispanic women aged 21–64, who are non-compliant with Papanicolau (Pap) test screening guidelines. Participants will be randomized using block randomization to (1) a control arm (usual care); (2) a low-intensity information program, consisting of a Spanish-language video that educates women on the importance of cervical cancer screening; or (3) a high-intensity program consisting of the video plus a ‘promotora’ or lay-community health educator-led, home based intervention to encourage cervical cancer screening. Participants who attend cervical cancer screening, and receive a diagnosis of an abnormal Pap test will be assigned to a patient navigator who will provide support and information to promote adherence to follow-up tests, and any necessary surgery or treatment. Primary endpoint: Participants will be tracked via medical record review at community-based clinics, to identify women who have had a Pap test within 7 months of baseline assessment. Medical record reviewers will be blinded to randomization arm. Secondary endpoint: An evaluation of the patient navigator program as a method to improve adherence and reduce time to follow-up among participants who receive an abnormal Pap test result. An additional secondary endpoint is the cost-effectiveness of the two different intensity intervention programs.

Discussion

This culturally sensitive intervention aims to increase compliance and adherence to cervical screening in a Hispanic population. If effective, such interventions may reduce incidence of cervical cancer.

Trial registration

NCT01525433

【 授权许可】

   
2012 Duggan et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]International Agency for Research on Cancer (IARC) Working Group: The Evaluation of Cervical Cancer Screening Programmes. Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. Br Med J 1986, 293(6548):659-664.
• [2]Sasieni PD, Cuzick J, Lynch-Farmery E: Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group. Br J Cancer 1996, 73(8):1001-1005.
• [3]US Department of Health and Human Services: US Preventive Services Task Force: Screening for Cervical Cancer. Recommendations and Rationale. In Agency for Healthcare Research and Quality. AHRQ Publication, Washington DC; 2003. No. 03-515A
• [4]Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA (Eds): SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). National Cancer Institute, Bethesda; 2012. http://seer.cancer.gov/csr/1975_2009_pops09/, based on November 2011 SEER data submission, posted to the SEER web site
• [5]American Cancer Society: Cancer Prevention & Early Detection Facts & Figures 2009. American Cancer Society, Atlanta, GA; 2009:i-64.
• [6]Engelstad LP, Stewart SL, Nguyen BH, Bedeian KL, Rubin MM, Pasick RJ, Hiatt RA: Abnormal Pap smear follow-up in a high-risk population. Cancer Epidemiol Biomarkers Prev 2001, 10(10):1015-1020.
• [7]Jones HW: Clinical treatment of women with atypical squamous cells of undetermined significance or atypical glandular cells of undetermined significance cervical cytology. Clin Obstet Gynecol 2000, 43(2):381-393.
• [8]Bazargan M, Bazargan SH, Farooq M, Baker RS: Correlates of cervical cancer screening among underserved Hispanic and African-American women. Prev Med 2004, 39(3):465-473.
• [9]Johnson CE, Mues KE, Mayne SL, Kiblawi AN: Cervical cancer screening among immigrants and ethnic minorities: a systematic review using the Health Belief Model. J Low Genit Tract Dis 2008, 12(3):232-241.
• [10]Harmon MP, Castro FG, Coe K: Acculturation and cervical cancer: knowledge, beliefs, and behaviors of Hispanic women. Women Health 1996, 24(3):37-57.
• [11]Scarinci IC, Garcia FA, Kobetz E, Partridge EE, Brandt HM, Bell MC, Dignan M, Ma GX, Daye JL, Castle PE: Cervical cancer prevention: new tools and old barriers. Cancer 2010, 116(11):2531-2542.
• [12]U.S. Census Bureau: U.S. Census Bureau, Detailed Tables: Yakima County, Washington. U.S. Census Bureau, American Fact Finder, Yakima County, WA; 2002. http://factfinder2.census.gov/faces/nav/jsf/pages/index.xhtml
• [13]Coronado GD, Farias A, Thompson B, Godina R, Oderkirk W: Attitudes and beliefs about colorectal cancer among Mexican Americans in communities along the US-Mexico border. Ethn Dis 2006, 16(2):421-427.
• [14]Byrd TL, Wilson KM, Smith JL, Heckert AL, Orians C, Vernon SW, Fernandez-Esquer M, Fernandez ME: Using Intervention Mapping as a Participatory Strategy: Development of a Cervical Cancer Intervention for Hispanic Women. Health Educ Behav 2012. Epub ahead of print
• [15]Hansen LK, Feigl P, Modiano MR, Lopez JA, Escobedo Sluder S, Moinpour CM, Pauler DK, Meyskens FL: An educational program to increase cervical and breast cancer screening in Hispanic women: a Southwest Oncology Group study. Cancer Nurs 2005, 28(1):47-53.
• [16]Hunter JB, de Zapien JG, Papenfuss M, Fernandez ML, Meister J, Giuliano AR: The impact of a promotora on increasing routine chronic disease prevention among women aged 40 and older at the U.S.-Mexico border. Health Educ Behav 2004, 31(4 Suppl):18S-28S.
• [17]Larkey L: Las mujeres saludables: reaching Latinas for breast, cervical and colorectal cancer prevention and screening. J Community Health 2006, 31(1):69-77.
• [18]Larkey LK, Gonzalez JA, Mar LE, Glantz N: Latina recruitment for cancer prevention education via Community Based Participatory Research strategies. Contemp Clin Trials 2009, 30(1):47-54.
• [19]Changing health behaviour intervention and research with social cognition models. Open University Press, Bukingham, UK; 2002.
• [20]Bandura A: Self-Efficacy: Toward a Unifying Theory of Behavioral Change. Psychol Rev 1977, 84(2):191-215.
• [21]Freeman HP: A model patient navigator program. Oncol Issues 2004, 19:44-47.
• [22]Dohan D, Schrag D: Using navigators to improve care of underserved patients. Cancer 2005, 104:848-855.